For pancreatic cancer, preclinical studies have found that a new curcumin synthesis derivative (CDF) can inhibit VEGF, IL-6 and tumour stem cells, thus affecting the TME of pancreatic cancer [111]. The gene discussed is VEGFA; the disease is familial pancreatic carcinoma.